Primary Health Properties PLC
Director's & PDMR dealings
Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investors in modern primary healthcare facilities, announces the following share dealing by a person closely associated with a Person Discharging Managerial Responsibilities ("PDMR's").
The Notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the UK Market Abuse Regulation.
| 1 | Details of Person Discharging Managerial Responsibility/person closely associated with them ("PCA") | ||
| (a) | Name | Philippa Bateman
| |
| 2 | Reason for the notification | ||
| (a) | Position/status | PCA, being the wife of David Bateman, Chief Investment Officer and PDMR
| |
| (b) | Initial notification/ amendment | Initial notification
| |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
| (a) | Name of Entity
| Primary Health Properties PLC | |
| (b) | Legal Entity Identifier | 213800Y5CJHXOATK7X11
| |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
| (a) | Description of the financial instrument | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
| (b) | Nature of the transaction | Purchase by ISA in dividend re-investment plan
| |
| (c) | Aggregated information Price(s) and volume(s) | Price(s) | Volume(s) |
| £0.898 | 749 | ||
| (d) | Aggregated volume price | Single transaction £672.26
| |
| (e) | Date of transaction | 27 February 2024
| |
| (f) | Place of transaction | London Stock Exchange (xlon)
| |
For further information
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer
+44(0) 7729 047 959
Legal Entity Identifier: 213800Y5CJHXOATK7X11
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.